Depression as a risk factor for Alzheimer’s disease: Genes, steroids, cytokines and neurogenesis – What do we need to know?

Abstract

Depression (MDD) is prodromal to, and a component of, Alzheimer's disease (AD): it may also be a trigger for incipient AD. MDD is not a unitary disorder, so there may be particular subtypes of early life MDD that pose independent high risks for later AD, though the identification of these subtypes is problematical. There may either be a common pathological event underlying both MDD and AD, or MDD may sensitize the brain to a second event ('hit') that precipitates AD. MDD may also accelerate brain ageing, including altered DNA methylation, increased cortisol but decreasing DHEA and thus the risk for AD. So far, genes predicting AD (e.g. APOEε4) are not risk factors for MDD, and those implicated in MDD (e.g. SLC6A4) are not risks for AD, so a common genetic predisposition looks unlikely. There is as yet no strong indication that an epigenetic event occurs during some forms of MDD that predisposes to later AD, though the evidence is limited. Glucocorticoids (GCs) are disturbed in some cases of MDD and in AD. GCs have marked degenerative actions on the hippocampus, a site of early β-amyloid deposition, and rare genetic variants of GC-regulating enzymes (e.g. 11β-HSD) predispose to AD. GCs also inhibit hippocampal neurogenesis and plasticity, and thus episodic memory, a core symptom of AD. Disordered GCs in MDD may inhibit neurogenesis, but the contribution of diminished neurogenesis to the onset or progression of AD is still debated. GCs and cytokines also reduce BDNF, implicated in both MDD and AD and hippocampal neurogenesis, reinforcing the notion that those cases of MDD with disordered GCs may be a risk for AD. Cytokines, including IL1β, IL6 and TNFα, are increased in the blood in some cases of MDD. They also reduce hippocampal neurogenesis, and increased cytokines are a known risk for later AD. Inflammatory changes occur in both MDD and AD (e.g. raised CRP, TNFα). Both cytokines and GCs can have pro-inflammatory actions in the brain. Inflammation (e.g. microglial activation) may be a common link, but this has not been systematically investigated. We lack substantial, rigorous and comprehensive follow-up studies to better identify possible subtypes of MDD that may represent a major predictor for later AD. This would enable specific interventions during critical episodes of these subtypes of MDD that should reduce this substantial risk.

A systematic review of yoga for major depressive disorder

“…Depression is one of the most prevalent psychiatric disorders as it affects 25% of women and 12% of men during their lifetime and increases the psychological strain for the affected person (Kessler et al, 2003;Moussavi et al, 2007;Rubio et al, 2011). Moreover, depression is characterized by a high comorbidity with several chronic conditions like addictions (Lai et al, 2015), neurodegenerative diseases (Herbert and Lucassen, 2016;Riccelli et al, 2016) or different psychiatric diseases (Azar et al, 2016;Chechko et al, 2016;Chen et al, 2016;Ronconi et al, 2015) can be observed. Depression is projected as one of the leading causes of disability worldwide (Global Burden of Disease Study Collaborators, 2015).…”

A Concept to Improve Care for People with Dementia

“…Furthermore, losing the ability to communicate can path dementia patients way to emotional problems, having to experience anxiety, frustration, anger and depression [44], [59,60]. These symptoms may also exist when the patient start to reply more others to complete their daily tasks, unable to maintain their interest and participating in different activities, brain disorder and presence of physical symptoms such as pain, loss of appetite and lack of energy deal to the dementia disease [61,62].…”

Alzheimer’s Disease Prevention - A Review of Modifiable Risk Factors and the Role of Dietary Supplements

“…In addition, studies have shown that major depressive disorder in mid-life is considered an independent risk factor for AD [54]. The exact mechanism of this association is unknown but may be related to raised cytokines, increased brain inflammation and aberrant hypothalamic pituitary axis function [55].…”